Umbilical vein injection for management of retained placenta

A randomized controlled trial of intra-umbilical vein ergometrine as compared to intramuscular oxytocin for management of third stage of labor

“…A similar observation was noted by Nardin et al [12] who compared IUVI of oxytocin solution compared to saline, and showed a reduction in manual removal of the placenta that was not statistically significant (p = 0.661). This the lack of significance could be explained by the relative infrequency of occurrence of retained placenta in this group (1.9%) and this compares well to the reported prevalence in the literature (3%) [13,14].…”

A randomized controlled trial of intra-umbilical vein ergometrine as compared to intramuscular oxytocin for management of third stage of labor

“…A similar observation was noted by Nardin et al [12] who compared IUVI of oxytocin solution compared to saline, and showed a reduction in manual removal of the placenta that was not statistically significant (p = 0.661). This the lack of significance could be explained by the relative infrequency of occurrence of retained placenta in this group (1.9%) and this compares well to the reported prevalence in the literature (3%) [13,14].…”

Clinical algorithms for management of third stage abnormalities

“…One was the Mousa 2014 PPH overview, 31 which indicates that there is minimal evidence on surgical procedures, and the Chongsomchai review, which recommends prophylactic antibiotics after manual removal of placenta (MROP) 42 . Three were on treatments found to be ineffective: intra‐umbilical vein oxytocin, 39,55 nitroglycerine 40 and prostaglandins 41 …”

Preliminary efficacy, feasibility and safety of intra-umbilical oxytocin to reduce the time to placental delivery at caesarean section: an exploratory randomized trial

“… 9 The Cochrane Database of Systematic Reviews supported the use of intra-umbilical oxytocin in a saline solution for the treatment of a retained placenta. 12 The subsequent “Release Study” could not replicate those results. 13 whereas other trials found the administration of intra-umbilical oxytocin to be beneficial.…”

A randomized controlled trial of intra-umbilical vein ergometrine as compared to intramuscular oxytocin for management of third stage of labor

“…A similar observation was noted by Nardin et al [12] who compared IUVI of oxytocin solution compared to saline, and showed a reduction in manual removal of the placenta that was not statistically significant (p = 0.661). This the lack of significance could be explained by the relative infrequency of occurrence of retained placenta in this group (1.9%) and this compares well to the reported prevalence in the literature (3%) [13,14].…”

Clinical algorithms for management of third stage abnormalities

“…One was the Mousa 2014 PPH overview, 31 which indicates that there is minimal evidence on surgical procedures, and the Chongsomchai review, which recommends prophylactic antibiotics after manual removal of placenta (MROP) 42 . Three were on treatments found to be ineffective: intra‐umbilical vein oxytocin, 39,55 nitroglycerine 40 and prostaglandins 41 …”

Preliminary efficacy, feasibility and safety of intra-umbilical oxytocin to reduce the time to placental delivery at caesarean section: an exploratory randomized trial

“… 9 The Cochrane Database of Systematic Reviews supported the use of intra-umbilical oxytocin in a saline solution for the treatment of a retained placenta. 12 The subsequent “Release Study” could not replicate those results. 13 whereas other trials found the administration of intra-umbilical oxytocin to be beneficial.…”

A randomized controlled trial of intra-umbilical vein ergometrine as compared to intramuscular oxytocin for management of third stage of labor

“…A similar observation was noted by Nardin et al [12] who compared IUVI of oxytocin solution compared to saline, and showed a reduction in manual removal of the placenta that was not statistically significant (p = 0.661). This the lack of significance could be explained by the relative infrequency of occurrence of retained placenta in this group (1.9%) and this compares well to the reported prevalence in the literature (3%) [13,14].…”

Clinical algorithms for management of third stage abnormalities

“…One was the Mousa 2014 PPH overview, 31 which indicates that there is minimal evidence on surgical procedures, and the Chongsomchai review, which recommends prophylactic antibiotics after manual removal of placenta (MROP) 42 . Three were on treatments found to be ineffective: intra‐umbilical vein oxytocin, 39,55 nitroglycerine 40 and prostaglandins 41 …”

Preliminary efficacy, feasibility and safety of intra-umbilical oxytocin to reduce the time to placental delivery at caesarean section: an exploratory randomized trial

“… 9 The Cochrane Database of Systematic Reviews supported the use of intra-umbilical oxytocin in a saline solution for the treatment of a retained placenta. 12 The subsequent “Release Study” could not replicate those results. 13 whereas other trials found the administration of intra-umbilical oxytocin to be beneficial.…”